 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||| XY03-EA / Shijiazhuang Yiling Pharma
Enrollment open, Trial completion date, Trial primary completion date: A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke (clinicaltrials.gov) - Jun 22, 2023
P2, N=420, Enrolling by invitation, Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Not yet recruiting --> Enrolling by invitation | Trial completion date: Aug 2024 --> Dec 2023 | Trial primary completion date: Aug 2024 --> Dec 2023
- ||||| XY03-EA / Shijiazhuang Yiling Pharma
New P2 trial: A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke (clinicaltrials.gov) - Aug 25, 2022
P2, N=420, Not yet recruiting, Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd